https://news.medxy.ai/zh/outcomes-of-colorectal-dysplasia-and-cancer-in-psc-ibd-liver-transplantation-and-colectomy/Medxy AIzh2026-07-15T10:16:25-07:00PSC-IBD患者行肝移植与结肠切除的结直肠异型增生和癌症结局：一项多中心研究 https://news.medxy.ai/ja/outcomes-of-colorectal-dysplasia-and-cancer-in-patients-with-psc-ibd/Medxy AIja2026-07-15T10:16:01-07:00PSC-IBD合併患者における大腸異形成・大腸癌の転帰：肝移植と結腸切除の順序を検討した多施設研究 https://news.medxy.ai/vi/outcomes-of-colorectal-dysplasia-and-cancer-in-patients-with-psc-ibd-undergoing-liver-transplantation-and-colectomy/Medxy AIvi2026-07-15T10:15:34-07:00Kết cục loạn sản và ung thư đại trực tràng ở bệnh nhân PSC-IBD sau ghép gan và cắt đại tràng: Góc nhìn từ một nghiên cứu đa trung tâm https://news.medxy.ai/outcomes-of-colorectal-dysplasia-and-cancer-in-patients-with-psc-ibd-undergoing-liver-transplantation-and-colectomy-insights-from-a-multicenter-study/Medxy AIen2026-07-15T10:14:41-07:00Outcomes of Colorectal Dysplasia and Cancer in Patients with PSC-IBD Undergoing Liver Transplantation and Colectomy: Insights from a Multicenter Study https://news.medxy.ai/zh/intraoperative-margin-assessment-in-early-stage-breast-cancer-with-pet-ct-imaging/Medxy AIzh2026-07-15T10:11:15-07:00标本 PET-CT 助力早期乳腺癌术中切缘评估：BrIMA 试验带来的新启示 https://news.medxy.ai/ja/intraoperative-margin-assessment-in-early-stage-breast-cancer-with-specimen-pet-ct-imaging/Medxy AIja2026-07-15T10:10:49-07:00標本PET-CTで早期乳がんの術中断端評価を高度化：BrIMA試験の知見 https://news.medxy.ai/vi/enhancing-intraoperative-margin-assessment-in-early-stage-breast-cancer-with-specimen-pet-ct-imaging/Medxy AIvi2026-07-15T10:10:18-07:00PET-CT trên bệnh phẩm giúp nâng cao đánh giá diện cắt trong mổ ở ung thư vú giai đoạn sớm: Góc nhìn từ thử nghiệm BrIMA https://news.medxy.ai/enhancing-intraoperative-margin-assessment-in-early-stage-breast-cancer-with-specimen-pet-ct-imaging-insights-from-the-brima-trial/Medxy AIen2026-07-15T10:08:56-07:00Enhancing Intraoperative Margin Assessment in Early-Stage Breast Cancer with Specimen PET-CT Imaging: Insights from the BrIMA Trial https://news.medxy.ai/zh/endobarrier-duodenal-jejunal-bypass-liner-for-glycemic-control-and-weight-loss-in-t2dm/Medxy AIzh2026-07-15T10:08:39-07:00EndoBarrier十二指肠-空肠旁路衬套：一种用于改善2型糖尿病合并肥胖患者血糖控制与减重的创新性内镜辅助治疗 https://news.medxy.ai/ja/endobarrier-duodenal-jejunal-bypass-liner-for-improved-glycemic-control-and-weight-loss-in-t2dm/Medxy AIja2026-07-15T10:08:16-07:00EndoBarrier十二指腸‐空腸バイパスライナー：肥満を伴う2型糖尿病に対する血糖改善・減量を目指す新しい内視鏡補助療法 https://news.medxy.ai/vi/endobarrier-duodenal-jejunal-bypass-liner-a-novel-endoscopic-adjunct-for-improved-glycemic-control-and-weight-loss-in-t2dm/Medxy AIvi2026-07-15T10:07:47-07:00EndoBarrier duodenal-jejunal bypass liner: Thiết bị nội soi mới giúp cải thiện kiểm soát đường huyết và giảm cân ở đái tháo đường type 2 kèm béo phì https://news.medxy.ai/endobarrier-duodenal-jejunal-bypass-liner-a-novel-endoscopic-adjunct-for-improved-glycemic-control-and-weight-loss-in-type-2-diabetes-with-obesity/Medxy AIen2026-07-15T10:06:44-07:00EndoBarrier Duodenal-Jejunal Bypass Liner: A Novel Endoscopic Adjunct for Improved Glycemic Control and Weight Loss in Type 2 Diabetes with Obesity https://news.medxy.ai/zh/hrd-testing-and-myc-amplification-in-parp-inhibitor-use-in-brca-wild-type-ovarian-carcinoma-2/Medxy AIzh2026-07-15T10:00:03-07:00借助HRD检测与MYC扩增优化BRCA野生型高级别浆液性卵巢癌中的PARP抑制剂应用 https://news.medxy.ai/ja/hrd-testing-and-myc-amplification-in-parp-inhibitor-use-in-brca-wild-type-ovarian-carcinoma/Medxy AIja2026-07-15T09:59:42-07:00BRCA野生型高異型度漿液性卵巣癌におけるPARP阻害薬最適化のためのHRD検査とMYC増幅の活用 https://news.medxy.ai/vi/harnessing-hrd-testing-and-myc-amplification-in-parp-inhibitor-use-in-brca-wild-type-high-grade-serous-ovarian-carcinoma/Medxy AIvi2026-07-15T09:59:21-07:00Khai thác xét nghiệm HRD và khuếch đại MYC để tối ưu hóa sử dụng chất ức chế PARP trong ung thư biểu mô thanh dịch độ cao buồng trứng BRCA hoang dại https://news.medxy.ai/harnessing-hrd-testing-and-myc-amplification-to-optimize-parp-inhibitor-use-in-brca-wild-type-high-grade-serous-ovarian-carcinoma/Medxy AIen2026-07-15T09:58:18-07:00Harnessing HRD Testing and MYC Amplification to Optimize PARP Inhibitor Use in BRCA Wild-Type High-Grade Serous Ovarian Carcinoma https://news.medxy.ai/zh/severe-lead-poisoning-during-pregnancy/Medxy AIzh2026-07-15T09:29:19-07:00妊娠期重度铅中毒：纽约市19年观察性研究带来的启示 https://news.medxy.ai/ja/severe-lead-poisoning-during-pregnancy-from-a-19-year-study/Medxy AIja2026-07-15T09:29:04-07:00妊娠中の重度鉛中毒：19年間のNYC観察研究から得られた知見 https://news.medxy.ai/vi/severe-lead-poisoning-during-pregnancy-from-a-19-year-observational-study/Medxy AIvi2026-07-15T09:28:42-07:00Ngộ độc chì nặng trong thai kỳ: Những phát hiện từ nghiên cứu quan sát 19 năm tại Thành phố New York https://news.medxy.ai/severe-lead-poisoning-during-pregnancy-insights-from-a-19-year-nyc-observational-study/Medxy AIen2026-07-15T09:27:18-07:00Severe Lead Poisoning During Pregnancy: Insights from a 19-Year NYC Observational Study https://news.medxy.ai/zh/fibroblast-diversity-in-vaginal-wall-prolapse-from-single-nucleus-transcriptomics/Medxy AIzh2026-07-15T09:25:37-07:00阴道壁脱垂中成纤维细胞多样性的解析：来自单核转录组学的启示 https://news.medxy.ai/ja/fibroblast-diversity-in-vaginal-wall-prolapse-insights-from-single-nucleus-transcriptomics/Medxy AIja2026-07-15T09:25:21-07:00単一核トランスクリプトミクスで解く、膣壁脱出における線維芽細胞の多様性 https://news.medxy.ai/vi/unraveling-fibroblast-diversity-in-vaginal-wall-prolapse/Medxy AIvi2026-07-15T09:25:02-07:00Khám phá sự đa dạng của nguyên bào sợi trong sa thành âm đạo: góc nhìn từ transcriptomics đơn nhân https://news.medxy.ai/unraveling-fibroblast-diversity-in-vaginal-wall-prolapse-insights-from-single-nucleus-transcriptomics/Medxy AIen2026-07-15T09:24:01-07:00Unraveling Fibroblast Diversity in Vaginal Wall Prolapse: Insights from Single-Nucleus Transcriptomics https://news.medxy.ai/zh/reclassifying-pediatric-nafld-by-the-steatotic-liver-disease-framework/Medxy AIzh2026-07-15T09:12:29-07:00儿童 NAFLD 重新分类：来自多中心 NASH CRN 研究的脂肪性肝病框架新见解 https://news.medxy.ai/ja/reclassifying-pediatric-nafld-from-the-steatotic-liver-disease-framework/Medxy AIja2026-07-15T09:12:10-07:00小児NAFLDを再考する：多施設NASH CRN研究が示す脂肪性肝疾患枠組みの意義 https://news.medxy.ai/vi/reclassifying-pediatric-nafld-insights-from-the-steatotic-liver-disease-framework/Medxy AIvi2026-07-15T09:11:43-07:00Phân loại lại NAFLD ở trẻ em: Góc nhìn từ khung bệnh gan nhiễm mỡ trong nghiên cứu đa trung tâm NASH CRN https://news.medxy.ai/reclassifying-pediatric-nafld-insights-from-the-steatotic-liver-disease-framework-in-a-multicenter-nash-crn-study/Medxy AIen2026-07-15T09:10:23-07:00Reclassifying Pediatric NAFLD: Insights from the Steatotic Liver Disease Framework in a Multicenter NASH CRN Study https://news.medxy.ai/ja/longterm-risk-of-hepatocellular-carcinoma-after-clearance-of-hbs-antigen/Medxy AIja2026-07-14T22:53:42-07:00HBsAg消失後の肝細胞癌リスク：長期追跡で見えた年齢と肝硬変の影響 https://news.medxy.ai/vi/long-term-risk-of-hepatocellular-carcinoma-after-clearance-of-hbs-antigen/Medxy AIvi2026-07-14T22:53:25-07:00Nguy cơ dài hạn ung thư biểu mô tế bào gan sau khi HBsAg được thanh thải https://news.medxy.ai/long-term-risk-of-hepatocellular-carcinoma-after-clearance-of-hepatitis-b-surface-antigen/Medxy AIen2026-07-14T22:52:42-07:00Long-term Risk of Hepatocellular Carcinoma After Clearance of Hepatitis B Surface Antigen https://news.medxy.ai/vi/mad-mt-score-enhancing-patient-selection-for-mechanical-thrombectomy-in-distal-vessel-occlusions-2/Medxy AIvi2026-07-14T18:09:38-07:00MAD-MT: Công cụ mới giúp chọn đúng bệnh nhân cho lấy huyết khối cơ học ở tắc mạch não xa https://news.medxy.ai/mad-mt-score-enhancing-patient-selection-for-mechanical-thrombectomy-in-distal-vessel-occlusions/Medxy AIen2026-07-14T18:08:23-07:00MAD-MT Score: Enhancing Patient Selection for Mechanical Thrombectomy in Distal Vessel Occlusions https://news.medxy.ai/zh/prion-diseases-from-alzheimers-disease-by-plasma-nfl-p-tau217-ratio/Medxy AIzh2026-07-14T18:05:03-07:00用血浆生物标志物区分朊蛋白病与阿尔茨海默病：NfL/p-tau217 比值的关键作用 https://news.medxy.ai/ja/prion-diseases-from-alzheimers-disease-using-plasma-nfl-p-tau217-ratio/Medxy AIja2026-07-14T18:04:43-07:00血漿バイオマーカーでプリオン病とアルツハイマー病を見分ける：NfL/p-tau217比の決定的役割 https://news.medxy.ai/vi/discriminating-prion-diseases-from-alzheimers-disease-using-plasma-nfl-p-tau217-ratio/Medxy AIvi2026-07-14T18:04:15-07:00Phân biệt bệnh prion với bệnh Alzheimer bằng dấu ấn sinh học huyết tương: vai trò then chốt của tỷ lệ NfL/p-tau217 https://news.medxy.ai/discriminating-prion-diseases-from-alzheimers-disease-using-plasma-biomarkers-the-crucial-role-of-nfl-p-tau217-ratio/Medxy AIen2026-07-14T18:03:13-07:00Discriminating Prion Diseases from Alzheimer’s Disease Using Plasma Biomarkers: The Crucial Role of NfL/p-tau217 Ratio https://news.medxy.ai/zh/acute-neural-biomarker-elevations-after-amateur-soccer-heading-into-potential-brain-injury/Medxy AIzh2026-07-14T18:01:43-07:00业余足球头球后急性神经生物标志物升高：脑损伤风险的新线索 https://news.medxy.ai/ja/acute-neural-biomarker-after-amateur-soccer-heading/Medxy AIja2026-07-14T18:01:20-07:00アマチュアサッカーのヘディング後にみられる急性神経バイオマーカー上昇：脳障害リスクを考える https://news.medxy.ai/vi/acute-neural-biomarker-elevations-after-amateur-soccer-heading/Medxy AIvi2026-07-14T18:00:53-07:00Đánh đầu trong bóng đá nghiệp dư làm tăng cấp tính các dấu ấn sinh học thần kinh: gợi ý về nguy cơ tổn thương não https://news.medxy.ai/acute-neural-biomarker-elevations-after-amateur-soccer-heading-insights-into-potential-brain-injury/Medxy AIen2026-07-14T18:00:02-07:00Acute Neural Biomarker Elevations After Amateur Soccer Heading: Insights Into Potential Brain Injury https://news.medxy.ai/zh/immune-subtypes-in-t1dm/Medxy AIzh2026-07-14T17:57:19-07:001型糖尿病的免疫学分型新发现：解析疾病进展与个体化免疫治疗 https://news.medxy.ai/ja/immune-subtypes-in-type-1-diabetes/Medxy AIja2026-07-14T17:57:00-07:001型糖尿病における免疫サブタイプの違い：病勢進行と個別化免疫療法への示唆 https://news.medxy.ai/vi/immune-subtypes-in-type-1-diabetes-implications-for-disease-progression-and-personalized-immunotherapy/Medxy AIvi2026-07-14T17:56:40-07:00Đái tháo đường type 1 không đồng nhất về miễn dịch: ý nghĩa đối với tiến triển bệnh và miễn dịch trị liệu cá thể hóa https://news.medxy.ai/distinct-immune-subtypes-in-type-1-diabetes-implications-for-disease-progression-and-personalized-immunotherapy/Medxy AIen2026-07-14T17:55:44-07:00Distinct Immune Subtypes in Type 1 Diabetes: Implications for Disease Progression and Personalized Immunotherapy https://news.medxy.ai/zh/next-generation-pharmacotherapies-in-obesity-transforming-care/Medxy AIzh2026-07-14T15:09:54-07:00肥胖治疗新纪元：精准干预与多系统获益的下一代药物 https://news.medxy.ai/ja/pharmacotherapies-in-obesity-transforming-care-with-precision-and-multisystem-benefits/Medxy AIja2026-07-14T15:09:34-07:00肥満治療の新時代：精密医療と多面的ベネフィットをもたらす次世代薬物療法 https://news.medxy.ai/vi/next-generation-pharmacotherapies-in-obesity-transforming-care-with-precision-and-multisystem-benefits-2/Medxy AIvi2026-07-14T15:09:11-07:00Liệu pháp điều trị béo phì thế hệ mới: Chuyển đổi chăm sóc nhờ y học chính xác và lợi ích đa hệ thống https://news.medxy.ai/next-generation-pharmacotherapies-in-obesity-transforming-care-with-precision-and-multisystem-benefits/Medxy AIen2026-07-14T15:08:16-07:00Next-Generation Pharmacotherapies in Obesity: Transforming Care with Precision and Multisystem Benefits https://news.medxy.ai/vi/low-dose-antithymocyte-globulin-therapy-in-type-1-diabetes-real-world-insights-using-modified-quantitative-response-of-c-peptide/Medxy AIvi2026-07-14T15:07:44-07:00ATG liều thấp trong đái tháo đường type 1: Góc nhìn thực tế qua đáp ứng định lượng hiệu chỉnh của C-peptide https://news.medxy.ai/exploring-low-dose-antithymocyte-globulin-therapy-in-type-1-diabetes-real-world-insights-using-modified-quantitative-response-of-c-peptide/Medxy AIen2026-07-14T15:07:05-07:00Exploring Low-Dose Antithymocyte Globulin Therapy in Type 1 Diabetes: Real-World Insights Using Modified Quantitative Response of C-Peptide https://news.medxy.ai/vi/early-detection-of-subclinical-preheart-failure-in-rural-regions-via-mobile-cardiac-mri-and-telemedicine/Medxy AIvi2026-07-14T15:04:15-07:00HERZCHECK: Mở ra hướng phát hiện sớm suy tim tiền lâm sàng ở nông thôn bằng MRI tim di động và y tế từ xa https://news.medxy.ai/herzcheck-revolutionizing-early-detection-of-subclinical-preheart-failure-in-rural-regions-via-mobile-cardiac-mri-and-telemedicine/Medxy AIen2026-07-14T15:03:30-07:00HERZCHECK: Revolutionizing Early Detection of Subclinical Preheart Failure in Rural Regions via Mobile Cardiac MRI and Telemedicine https://news.medxy.ai/zh/maternal-diabetes-increase-the-risk-of-early-onset-cardiovascular-disease-in-offspring/Medxy AIzh2026-07-14T14:37:22-07:00母体糖尿病与子代早发心血管疾病风险升高：来自瑞典全国队列研究的启示 https://news.medxy.ai/ja/maternal-diabetes-and-the-risk-of-early-onset-cardiovascular-disease-in-offspring/Medxy AIja2026-07-14T14:37:06-07:00母体糖尿病は子どもの早発心血管疾患リスクを高める：スウェーデン全国コホート研究からの知見 https://news.medxy.ai/vi/maternal-diabetes-and-the-elevated-risk-of-early-onset-cardiovascular-disease-in-offspring/Medxy AIvi2026-07-14T14:36:47-07:00Đái tháo đường của mẹ và nguy cơ bệnh tim mạch khởi phát sớm ở con: bằng chứng từ một nghiên cứu đoàn hệ toàn quốc tại Thụy Điển https://news.medxy.ai/maternal-diabetes-and-the-elevated-risk-of-early-onset-cardiovascular-disease-in-offspring-insights-from-a-swedish-nationwide-cohort-study/Medxy AIen2026-07-14T14:36:06-07:00Maternal Diabetes and the Elevated Risk of Early-Onset Cardiovascular Disease in Offspring: Insights from a Swedish Nationwide Cohort Study https://news.medxy.ai/ja/wine-consumption-mediterranean-diet-and-cardiovascular-disease/Medxy AIja2026-07-14T14:08:02-07:00地中海食とワイン摂取は心血管リスクにどう関わるか――スペイン2コホート研究 https://news.medxy.ai/vi/wine-consumption-mediterranean-diet-and-cardiovascular-risk/Medxy AIvi2026-07-14T14:07:44-07:00Rượu vang, chế độ ăn Địa Trung Hải và nguy cơ tim mạch: bằng chứng từ hai đoàn hệ Tây Ban Nha https://news.medxy.ai/wine-consumption-mediterranean-diet-and-cardiovascular-risk-in-two-spanish-cohorts/Medxy AIen2026-07-14T14:07:10-07:00Wine Consumption, Mediterranean Diet, and Cardiovascular Risk in Two Spanish Cohorts https://news.medxy.ai/zh/orbita-cto-evaluating-percutaneous-coronary-intervention-on-symptomatic-chronic-total-occlusion-in-stable-angina/Medxy AIzh2026-07-14T14:03:44-07:00ORBITA-CTO试验：评估经皮冠状动脉介入治疗对稳定型心绞痛症状性慢性完全闭塞的影响 https://news.medxy.ai/ja/orbita-cto%e8%a9%a6%e9%a8%93%ef%bc%9a%e5%ae%89%e5%ae%9a%e7%8b%ad%e5%bf%83%e7%97%87%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e7%97%87%e5%80%99%e6%80%a7%e6%85%a2%e6%80%a7%e5%ae%8c%e5%85%a8%e9%96%89%e5%a1%9e/Medxy AIja2026-07-14T14:03:20-07:00ORBITA-CTO試験：安定狭心症における症候性慢性完全閉塞への経皮的冠動脈インターベンションの影響を検証 https://news.medxy.ai/vi/orbita-cto-trial-evaluating-percutaneous-coronary-intervention-on-symptomatic-chronic-total-occlusion-in-stable-angina/Medxy AIvi2026-07-14T14:03:00-07:00ORBITA-CTO: Đánh giá tác động của can thiệp mạch vành qua da lên tắc nghẽn mạn tính hoàn toàn có triệu chứng trong đau thắt ngực ổn định https://news.medxy.ai/orbita-cto-trial-evaluating-the-impact-of-percutaneous-coronary-intervention-on-symptomatic-chronic-total-occlusion-in-stable-angina/Medxy AIen2026-07-14T14:02:19-07:00ORBITA-CTO Trial: Evaluating the Impact of Percutaneous Coronary Intervention on Symptomatic Chronic Total Occlusion in Stable Angina https://news.medxy.ai/vi/microplastic-exposure-and-cardiomyopathy-unveiling-the-gut-heart-axis/Medxy AIvi2026-07-14T13:47:52-07:00Phơi nhiễm vi nhựa và bệnh cơ tim: Hé lộ cơ chế trục ruột-tim https://news.medxy.ai/microplastic-exposure-and-cardiomyopathy-unveiling-the-gut-heart-axis-mechanism/Medxy AIen2026-07-14T13:47:08-07:00Microplastic Exposure and Cardiomyopathy: Unveiling the Gut-Heart Axis Mechanism https://news.medxy.ai/zh/consolidative-thoracic-radiotherapy-with-atezolizumab-maintenance-in-es-sclc/Medxy AIzh2026-07-14T11:33:00-07:00广泛期小细胞肺癌中巩固性胸部放疗联合阿替利珠单抗维持：TREASURE 2期试验带来的启示 https://news.medxy.ai/ja/consolidative-thoracic-radiotherapy-with-atezolizumab-maintenance-in-extensive-stage-sclc/Medxy AIja2026-07-14T11:32:41-07:00進展型小細胞肺癌に対するアテゾリズマブ維持療法への胸部集学的放射線療法追加を検証：第2相TREASURE試験の知見 https://news.medxy.ai/vi/consolidative-thoracic-radiotherapy-with-atezolizumab-maintenance-in-extensive-stage-small-cell-lung-cancer/Medxy AIvi2026-07-14T11:32:19-07:00Xạ trị lồng ngực củng cố kết hợp duy trì atezolizumab trong ung thư phổi tế bào nhỏ giai đoạn lan rộng: Kết quả nổi bật từ thử nghiệm TREASURE pha 2 https://news.medxy.ai/evaluating-consolidative-thoracic-radiotherapy-with-atezolizumab-maintenance-in-extensive-stage-small-cell-lung-cancer/Medxy AIen2026-07-14T11:31:23-07:00Evaluating Consolidative Thoracic Radiotherapy with Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: Insights from the Phase 2 TREASURE Trial https://news.medxy.ai/zh/ctdna-outperforms-for-monitoring-recurrence-in-merkel-cell-carcinoma/Medxy AIzh2026-07-14T10:58:06-07:00ctDNA在Merkel细胞癌复发监测中优于MCPyV抗体检测 https://news.medxy.ai/ja/ctdna-outperforms-merkel-cell-polyomavirus-antibodies-for-recurrence-in-merkel-cell-carcinoma/Medxy AIja2026-07-14T10:57:50-07:00メルケル細胞癌の再発監視ではctDNAがMCPyV抗体を上回る https://news.medxy.ai/vi/ctdna-outperforms-merkel-cell-polyomavirus-antibodies-for-monitoring-recurrence-in-merkel-cell-carcinoma/Medxy AIvi2026-07-14T10:57:31-07:00ctDNA vượt trội hơn kháng thể MCPyV trong theo dõi tái phát ung thư biểu mô tế bào Merkel https://news.medxy.ai/circulating-tumor-dna-outperforms-merkel-cell-polyomavirus-antibodies-for-monitoring-recurrence-in-merkel-cell-carcinoma/Medxy AIen2026-07-14T10:56:44-07:00Circulating Tumor DNA Outperforms Merkel Cell Polyomavirus Antibodies for Monitoring Recurrence in Merkel Cell Carcinoma https://news.medxy.ai/zh/institutional-and-insurance-linked-disparities-in-melanoma-outcomes/Medxy AIzh2026-07-14T10:38:23-07:00黑色素瘤结局中的机构与保险差异：来自 VA 中心与三级医疗中心队列研究的启示 https://news.medxy.ai/ja/institutional-and-insurance-linked-disparities-in-melanoma-outcomes-insights-from-a-va-and-tertiary-care-cohort-study/Medxy AIja2026-07-14T10:38:01-07:00メラノーマ転帰の施設差・保険差を探る：VAセンターと三次医療コホートからの知見 https://news.medxy.ai/vi/exploring-institutional-and-insurance-linked-disparities-in-melanoma-outcomes/Medxy AIvi2026-07-14T10:37:40-07:00U hắc tố: khác biệt về kết cục giữa cơ sở điều trị và bảo hiểm trong một nghiên cứu đoàn hệ từ VA và trung tâm chăm sóc bậc ba https://news.medxy.ai/exploring-institutional-and-insurance-linked-disparities-in-melanoma-outcomes-insights-from-a-va-and-tertiary-care-cohort-study/Medxy AIen2026-07-14T10:36:47-07:00Exploring Institutional and Insurance-Linked Disparities in Melanoma Outcomes: Insights from a VA and Tertiary Care Cohort Study https://news.medxy.ai/zh/misconceptions-about-hyaluronic-acid-fillers-for-optimal-aesthetic-outcomes/Medxy AIzh2026-07-14T10:23:18-07:00破除误区：如何应对患者对透明质酸填充剂的认知偏差，以实现理想审美效果 https://news.medxy.ai/ja/navigating-patient-misconceptions-about-hyaluronic-acid-fillers-for-aesthetic-outcomes/Medxy AIja2026-07-14T10:22:59-07:00ヒアルロン酸フィラーの誤解を解く：自然な仕上がりをかなえる患者対応の要点 https://news.medxy.ai/vi/navigating-patient-misconceptions-about-hyaluronic-acid-for-optimal-aesthetic-outcomes/Medxy AIvi2026-07-14T10:22:34-07:00Xóa bỏ hiểu lầm: Hiểu đúng quan niệm của bệnh nhân về chất làm đầy acid hyaluronic để tối ưu kết quả thẩm mỹ https://news.medxy.ai/navigating-patient-misconceptions-about-hyaluronic-acid-fillers-for-optimal-aesthetic-outcomes/Medxy AIen2026-07-14T10:21:43-07:00Dispelling Myths: Navigating Patient Misconceptions About Hyaluronic Acid Fillers for Optimal Aesthetic Outcomes https://news.medxy.ai/zh/facial-reanimation-outcomes-of-fascia-lata-suspension-in-triple-nerve-transfer-procedures/Medxy AIzh2026-07-14T10:17:32-07:00提升面部复苏效果：三重神经移位术中联合阔筋膜张肌筋膜悬吊的价值 https://news.medxy.ai/ja/facial-reanimation-outcomes-the-impact-of-fascia-lata-suspension-in-triple-nerve-transfer/Medxy AIja2026-07-14T10:17:13-07:00顔面再活性化の成績を高める：Triple nerve transfer における fascia lata suspension の有用性 https://news.medxy.ai/vi/facial-reanimation-outcomes-the-impact-of-fascia-lata-suspension-in-triple-nerve-transfer-procedures/Medxy AIvi2026-07-14T10:16:46-07:00Cải thiện kết quả hồi sinh khuôn mặt: Vai trò của treo cân đùi trong chuyển ghép ba dây thần kinh https://news.medxy.ai/enhancing-facial-reanimation-outcomes-the-impact-of-fascia-lata-suspension-in-triple-nerve-transfer-procedures/Medxy AIen2026-07-14T10:15:37-07:00Enhancing Facial Reanimation Outcomes: The Impact of Fascia Lata Suspension in Triple Nerve Transfer Procedures https://news.medxy.ai/zh/the-economic-impact-of-enhanced-primary-youth-mental-health-services/Medxy AIzh2026-07-14T10:09:58-07:00强化青少年初级精神卫生服务的经济价值：来自 ACCESS Open Minds 研究的启示 https://news.medxy.ai/ja/enhanced-primary-youth-mental-health-services/Medxy AIja2026-07-14T10:09:38-07:00強化された若年精神保健の経済効果を検証する：ACCESS Open Minds 研究から見える成果 https://news.medxy.ai/vi/evaluating-the-economic-impact-of-enhanced-primary-youth-mental-health-services/Medxy AIvi2026-07-14T10:09:18-07:00Đánh giá tác động kinh tế của các dịch vụ sức khỏe tâm thần ban đầu tăng cường cho thanh thiếu niên: Góc nhìn từ nghiên cứu ACCESS Open Minds https://news.medxy.ai/evaluating-the-economic-impact-of-enhanced-primary-youth-mental-health-services-insights-from-the-access-open-minds-study/Medxy AIen2026-07-14T10:07:54-07:00Evaluating the Economic Impact of Enhanced Primary Youth Mental Health Services: Insights from the ACCESS Open Minds Study https://news.medxy.ai/vi/effectiveness-of-dialectical-behavior-therapy-and-schema-therapy-in-borderline-personality-disorder/Medxy AIvi2026-07-14T09:34:38-07:00DBT hay ST: Hiệu quả điều trị nào tốt hơn cho rối loạn nhân cách ranh giới? Kết quả từ thử nghiệm BOOTS https://news.medxy.ai/comparative-effectiveness-of-dialectical-behavior-therapy-and-schema-therapy-in-borderline-personality-disorder/Medxy AIen2026-07-14T09:33:28-07:00Comparative Effectiveness of Dialectical Behavior Therapy and Schema Therapy in Borderline Personality Disorder: Insights from the BOOTS Trial https://news.medxy.ai/zh/sex-differences-in-critical-care-outcomes-3/Medxy AIzh2026-07-14T09:29:41-07:00印度最大ICU注册研究揭示：重症结局存在性别差异吗？ https://news.medxy.ai/ja/sex-differences-in-critical-care-outcomes-2/Medxy AIja2026-07-14T09:29:21-07:00ICU転帰にみる性差：インド最大級レジストリが示した知見 https://news.medxy.ai/vi/sex-differences-in-critical-care-outcomes-in-india/Medxy AIvi2026-07-14T09:29:02-07:00Khác biệt giới trong kết cục hồi sức tích cực: Những phát hiện từ cơ sở đăng ký ICU lớn nhất của Ấn Độ https://news.medxy.ai/sex-differences-in-critical-care-outcomes/Medxy AIen2026-07-14T09:27:33-07:00Sex Differences in Critical Care Outcomes: Insights from India’s Largest ICU Registry https://news.medxy.ai/zh/suicide-prevention-of-teen-and-caregiver-in-the-emergency-department/Medxy AIzh2026-07-14T09:21:22-07:00提升自杀预防：急诊科中青少年与照护者对致命手段安全规划的看法 https://news.medxy.ai/ja/enhancing-suicide-prevention-of-teen-and-caregiver-in-the-emergency-department/Medxy AIja2026-07-14T09:21:07-07:00救急外来における自殺予防を強化する：致死手段安全性計画をめぐるティーンと養育者の視点 https://news.medxy.ai/vi/enhancing-suicide-prevention-teen-and-caregiver-in-the-emergency-department/Medxy AIvi2026-07-14T09:20:47-07:00Tăng cường phòng ngừa tự sát: Góc nhìn của thanh thiếu niên và người chăm sóc về lập kế hoạch an toàn với phương tiện gây tử vong tại khoa cấp cứu https://news.medxy.ai/enhancing-suicide-prevention-teen-and-caregiver-views-on-lethal-means-safety-planning-in-the-emergency-department/Medxy AIen2026-07-14T09:19:45-07:00Enhancing Suicide Prevention: Teen and Caregiver Views on Lethal Means Safety Planning in the Emergency Department https://news.medxy.ai/zh/physical-restraint-use-in-mechanically-ventilated-icu-patients-impact-on-delirium-and-coma/Medxy AIzh2026-07-14T08:28:00-07:00机械通气 ICU 患者的物理约束使用：对 14 天内谵妄与昏迷无事件生存天数的影响 https://news.medxy.ai/ja/physical-restraint-use-in-mechanically-ventilated-icu-patients-free-days-over-14-days/Medxy AIja2026-07-14T08:27:08-07:00人工呼吸管理下ICU患者における身体拘束：14日間のせん妄・昏睡のない日数への影響 https://news.medxy.ai/vi/physical-restraint-use-in-mechanically-ventilated-icu-patients/Medxy AIvi2026-07-14T08:26:46-07:00Cố định thể chất ở bệnh nhân ICU thở máy: Ảnh hưởng lên sảng và số ngày không hôn mê trong 14 ngày https://news.medxy.ai/physical-restraint-use-in-mechanically-ventilated-icu-patients-impact-on-delirium-and-coma-free-days-over-14-days/Medxy AIen2026-07-14T08:25:04-07:00Physical Restraint Use in Mechanically Ventilated ICU Patients: Impact on Delirium and Coma-Free Days Over 14 Days https://news.medxy.ai/vi/prediction-of-survival-in-newly-diagnosed-chronic-graft-versus-host-disease-patients/Medxy AIvi2026-07-13T14:57:55-07:00Đánh giá sớm có hỗ trợ phần mềm giúp nâng cao khả năng dự đoán sống còn ở bệnh nhân bệnh ghép chống chủ mạn tính mới chẩn đoán https://news.medxy.ai/early-software-assisted-evaluation-enhances-prediction-of-survival-in-newly-diagnosed-chronic-graft-versus-host-disease-patients/Medxy AIen2026-07-13T14:57:17-07:00Early Software-Assisted Evaluation Enhances Prediction of Survival in Newly Diagnosed Chronic Graft-versus-Host Disease Patients https://news.medxy.ai/zh/cd7-car-t-cell-therapy-in-relapsed-refractory-cd7-positive-acute-myeloid-leukemia/Medxy AIzh2026-07-13T14:44:54-07:00CD7靶向CAR-T细胞治疗复发/难治性CD7阳性急性髓系白血病：临床进展与未来展望 https://news.medxy.ai/ja/cd7-directed-car-t-cell-therapy-in-relapsed-refractory-acute-myeloid-leukemia/Medxy AIja2026-07-13T14:44:29-07:00再発／難治性CD7陽性急性骨髄性白血病に対するCD7標的CAR-T細胞療法：臨床的進展と今後の展望 https://news.medxy.ai/vi/cd7-directed-car-t-cell-therapy-in-relapsed-refractory-cd7-positive-acute-myeloid-leukemia/Medxy AIvi2026-07-13T14:44:04-07:00Liệu pháp tế bào CAR-T hướng đích CD7 trong bệnh bạch cầu tủy cấp CD7 dương tính tái phát/kháng trị: tiến bộ lâm sàng và triển vọng tương lai https://news.medxy.ai/cd7-directed-car-t-cell-therapy-in-relapsed-refractory-cd7-positive-acute-myeloid-leukemia-clinical-advances-and-future-perspectives/Medxy AIen2026-07-13T14:43:08-07:00CD7-Directed CAR-T Cell Therapy in Relapsed/Refractory CD7-Positive Acute Myeloid Leukemia: Clinical Advances and Future Perspectives https://news.medxy.ai/zh/pavurutamab-in-triple-class-relapsed-refractory-multiple-myeloma-3/Medxy AIzh2026-07-13T14:41:22-07:00BCMA靶向双特异性T细胞接合器pavurutamab：三类药物暴露后复发/难治性多发性骨髓瘤1/1b期研究结果令人鼓舞 https://news.medxy.ai/ja/pavurutamab-in-triple-class-relapsed-refractory-multiple-myeloma-2/Medxy AIja2026-07-13T14:41:03-07:00BCMA標的二重特異性T細胞エンゲージャー・Pavurutamab：三剤群不応／再発多発性骨髄腫における第1/1b相で有望な結果 https://news.medxy.ai/vi/pavurutamab-in-triple-class-relapsed-refractory-multiple-myeloma/Medxy AIvi2026-07-13T14:40:42-07:00Pavurutamab: thuốc dẫn đường tế bào T nhắm BCMA cho đa u tủy xương tái phát/kháng trị kháng ba nhóm thuốc — kết quả pha 1/1b đầy hứa hẹn https://news.medxy.ai/pavurutamab-a-bcma-targeting-bispecific-t-cell-engager-promising-phase-1-1b-results-in-triple-class-relapsed-refractory-multiple-myeloma/Medxy AIen2026-07-13T14:39:56-07:00Pavurutamab, a BCMA-Targeting Bispecific T-Cell Engager: Promising Phase 1/1b Results in Triple-Class Relapsed/Refractory Multiple Myeloma https://news.medxy.ai/zh/cardiac-alterations-in-swimming-induced-pulmonary-edema-4/Medxy AIzh2026-07-13T14:39:02-07:00游泳诱发性肺水肿中的心脏改变：急性评估的临床启示 https://news.medxy.ai/ja/cardiac-alterations-in-swimming-induced-pulmonary-edema-3/Medxy AIja2026-07-13T14:38:45-07:00水泳誘発性肺水腫に伴う心臓変化：急性評価に役立つ臨床的示唆 https://news.medxy.ai/vi/cardiac-alterations-in-swimming-induced-pulmonary-edema-2/Medxy AIvi2026-07-13T14:38:22-07:00Biến đổi tim trong phù phổi do bơi lội: Ý nghĩa lâm sàng đối với đánh giá cấp cứu https://news.medxy.ai/cardiac-alterations-in-swimming-induced-pulmonary-edema/Medxy AIen2026-07-13T14:37:39-07:00Cardiac Alterations in Swimming-Induced Pulmonary Edema: Clinical Implications for Acute Evaluation https://news.medxy.ai/zh/prostaglandin-i2-receptor-jun-p53-pathway-drives-alveolar-regeneration-for-lung-repair/Medxy AIzh2026-07-13T14:36:46-07:00激活前列腺素I2受体：通过JUN/p53通路促进肺泡再生的新机制 https://news.medxy.ai/ja/prostaglandin-i2-receptor-activation-drives-alveolar-regeneration-via-jun-p53-pathway-for-lung-repair/Medxy AIja2026-07-13T14:36:30-07:00肺再生を切り拓く新知見：プロスタグランジンI2受容体活性化がJUN/p53経路を介して肺胞再生を促進 https://news.medxy.ai/vi/prostaglandin-i2-receptor-activation-drives-alveolar-regeneration-via-jun-p53-pathway/Medxy AIvi2026-07-13T14:36:10-07:00Khởi động quá trình phục hồi phổi: Hoạt hóa thụ thể Prostaglandin I2 thúc đẩy tái tạo phế nang qua trục JUN/p53 https://news.medxy.ai/unlocking-lung-repair-prostaglandin-i2-receptor-activation-drives-alveolar-regeneration-via-jun-p53-pathway/Medxy AIen2026-07-13T14:35:32-07:00Unlocking Lung Repair: Prostaglandin I2 Receptor Activation Drives Alveolar Regeneration via JUN/p53 Pathway https://news.medxy.ai/ja/tomographic-predictors-of-foveal-versus-extrafoveal-atrophy-onset-in-age-related-macular-degeneration/Medxy AIja2026-07-13T14:34:18-07:00中等度加齢黄斑変性における中心窩先行・中心窩外先行萎縮を見分けるOCT予測因子：臨床的意義とバイオマーカーの示唆 https://news.medxy.ai/vi/tomographic-predictors-of-atrophy-onset-in-intermediate-age-related-macular-degeneration/Medxy AIvi2026-07-13T14:33:54-07:00Dự đoán bằng OCT về thời điểm khởi phát teo tại hố trung tâm và ngoài hố trung tâm trong thoái hóa điểm vàng do tuổi tác giai đoạn trung gian: ý nghĩa lâm sàng và giá trị biomarker https://news.medxy.ai/tomographic-predictors-of-foveal-versus-extrafoveal-atrophy-onset-in-intermediate-age-related-macular-degeneration/Medxy AIen2026-07-13T14:32:49-07:00Tomographic Predictors of Foveal Versus Extrafoveal Atrophy Onset in Intermediate Age-Related Macular Degeneration: Clinical Implications and Biomarker Insights https://news.medxy.ai/vi/ocular-symptom-trajectories-after-refractive-surgery/Medxy AIvi2026-07-13T14:28:03-07:00Đau mắt sau phẫu thuật khúc xạ: các quỹ đạo triệu chứng khác nhau và gợi ý cho chăm sóc hậu phẫu cá thể hóa https://news.medxy.ai/distinct-ocular-symptom-trajectories-after-refractive-surgery/Medxy AIen2026-07-13T14:27:18-07:00Distinct Ocular Symptom Trajectories After Refractive Surgery: Insights for Personalized Postoperative Care https://news.medxy.ai/ja/visual-electrophysiology-in-glaucoma-4/Medxy AIja2026-07-13T14:25:25-07:00緑内障における視覚電気生理学：2026年AAO報告の要点 https://news.medxy.ai/vi/visual-electrophysiology-in-glaucoma-3/Medxy AIvi2026-07-13T14:24:51-07:00Điện sinh lý thị giác trong glaucoma: Những điểm then chốt từ báo cáo năm 2026 của American Academy of Ophthalmology https://news.medxy.ai/zh/visual-electrophysiology-in-glaucoma-2/Medxy AIzh2026-07-13T14:24:24-07:00青光眼中的视觉电生理：2026年美国眼科学会报告要点 https://news.medxy.ai/visual-electrophysiology-in-glaucoma/Medxy AIen2026-07-13T14:23:01-07:00Visual Electrophysiology in Glaucoma: Key Findings from the 2026 American Academy of Ophthalmology Report https://news.medxy.ai/zh/hypoglossal-nerve-stimulation-lowers-obstructive-sleep-apnea-patients/Medxy AIzh2026-07-13T14:17:16-07:00舌下神经刺激显著降低缺氧负荷并改善阻塞性睡眠呼吸暂停患者嗜睡症状：STAR 试验新发现 https://news.medxy.ai/ja/hypoglossal-nerve-stimulation-lowers-hypoxic-burden-and-improves-sleepiness-in-obstructive-sleep-apnea-patients/Medxy AIja2026-07-13T14:16:57-07:00舌下神経刺激療法は閉塞性睡眠時無呼吸の低酸素負荷を有意に低下させ、眠気も改善する：STAR試験からの知見 https://news.medxy.ai/vi/hypoglossal-nerve-stimulation-significantly-lowers-hypoxic-burden-and-improves-sleepiness-in-obstructive-sleep-apnea-patients/Medxy AIvi2026-07-13T14:16:36-07:00Kích thích dây thần kinh hạ thiệt giúp giảm gánh nặng thiếu oxy và cải thiện buồn ngủ ở bệnh nhân ngưng thở khi ngủ tắc nghẽn: Phân tích từ thử nghiệm STAR https://news.medxy.ai/hypoglossal-nerve-stimulation-significantly-lowers-hypoxic-burden-and-improves-sleepiness-in-obstructive-sleep-apnea-patients-insights-from-the-star-trial/Medxy AIen2026-07-13T14:15:54-07:00Hypoglossal Nerve Stimulation Significantly Lowers Hypoxic Burden and Improves Sleepiness in Obstructive Sleep Apnea Patients: Insights from the STAR Trial https://news.medxy.ai/zh/polysomnographic-characteristics-in-pediatric-obstructive-sleep-apnea/Medxy AIzh2026-07-13T14:14:32-07:00极端重度与极重度儿童阻塞性睡眠呼吸暂停的临床与多导睡眠监测特征差异 https://news.medxy.ai/ja/clinical-and-polysomnographic-characteristics-in-pediatric-obstructive-sleep-apnea/Medxy AIja2026-07-13T14:14:15-07:00小児の極重症OSAを見分ける臨床・PSG所見のポイント https://news.medxy.ai/vi/clinical-and-polysomnographic-characteristics-in-very-severe-pediatric-obstructive-sleep-apnea/Medxy AIvi2026-07-13T14:13:52-07:00Đặc điểm lâm sàng và đa ký giấc ngủ giúp phân biệt OSA tắc nghẽn cực kỳ nặng với rất nặng ở trẻ em https://news.medxy.ai/clinical-and-polysomnographic-characteristics-distinguishing-extreme-from-very-severe-pediatric-obstructive-sleep-apnea/Medxy AIen2026-07-13T14:13:12-07:00Clinical and Polysomnographic Characteristics Distinguishing Extreme from Very Severe Pediatric Obstructive Sleep Apnea https://news.medxy.ai/optimizing-prognostic-accuracy-in-duodenal-adenocarcinoma-evaluating-lymph-node-staging-schemes/Medxy AIen2026-07-13T14:06:21-07:00Optimizing Prognostic Accuracy in Duodenal Adenocarcinoma: Evaluating Lymph Node Staging Schemes and a Novel Nomogram https://news.medxy.ai/ja/nationwide-multimodal-prehabilitation-reduces-complications-in-colorectal-cancer-surgery/Medxy AIja2026-07-13T14:02:55-07:00大腸がん手術後の合併症を大幅に減らす全国的マルチモーダル・プレハビリテーション https://news.medxy.ai/vi/nationwide-multimodal-prehabilitation-reduces-complications-after-colorectal-cancer-surgery/Medxy AIvi2026-07-13T14:02:35-07:00Tiền phục hồi chức năng đa mô thức trên toàn quốc giúp giảm rõ rệt biến chứng sau phẫu thuật ung thư đại trực tràng https://news.medxy.ai/nationwide-multimodal-prehabilitation-significantly-reduces-complications-after-colorectal-cancer-surgery/Medxy AIen2026-07-13T14:01:50-07:00Nationwide Multimodal Prehabilitation Significantly Reduces Complications After Colorectal Cancer Surgery https://news.medxy.ai/zh/high-trauma-volume-hospitals-in-blunt-intestinal-injury/Medxy AIzh2026-07-13T14:00:31-07:00创伤量大的医院如何影响钝性肠损伤的及时手术管理 https://news.medxy.ai/ja/high-trauma-volume-hospitals-on-prompt-surgical-management-in-blunt-intestinal-injury/Medxy AIja2026-07-13T14:00:13-07:00外傷症例数の多い病院は鈍的腸損傷の迅速な手術管理にどう影響するか https://news.medxy.ai/vi/high-trauma-volume-hospitals-impact-on-prompt-surgical-management-in-blunt-intestinal-injury/Medxy AIvi2026-07-13T13:59:53-07:00Khối lượng chấn thương cao ở bệnh viện và tác động của nó đến xử trí phẫu thuật kịp thời trong tổn thương ruột kín https://news.medxy.ai/high-trauma-volume-hospitals-and-their-impact-on-prompt-surgical-management-in-blunt-intestinal-injury/Medxy AIen2026-07-13T13:59:12-07:00High Trauma Volume Hospitals and Their Impact on Prompt Surgical Management in Blunt Intestinal Injury https://news.medxy.ai/zh/assessing-readability-of-gynecologic-cancer-patient-education/Medxy AIzh2026-07-13T13:58:47-07:00妇科癌症患者教育材料可读性评估：弥合沟通鸿沟 https://news.medxy.ai/ja/readability-of-gynecologic-cancer-patient-education/Medxy AIja2026-07-13T13:58:30-07:00婦人科がん患者向け教育資料の可読性を検証する：コミュニケーション格差を埋めるために https://news.medxy.ai/vi/readability-of-gynecologic-cancer-patient-education-materials/Medxy AIvi2026-07-13T13:58:09-07:00Đánh giá mức độ dễ đọc của tài liệu giáo dục cho người bệnh ung thư phụ khoa: Thu hẹp khoảng cách giao tiếp https://news.medxy.ai/assessing-readability-of-gynecologic-cancer-patient-education-materials/Medxy AIen2026-07-13T13:57:29-07:00Assessing Readability of Gynecologic Cancer Patient Education Materials: Bridging the Communication Gap https://news.medxy.ai/zh/outcomes-of-retropubic-for-stress-urinary-incontinence/Medxy AIzh2026-07-13T13:50:45-07:00压力性尿失禁中段尿道吊带远期结局：耻骨后路径与经闭孔路径的再手术风险及并发症 https://news.medxy.ai/ja/long-term-outcomes-of-retropubic-for-stress-urinary-incontinence/Medxy AIja2026-07-13T13:50:25-07:00腹圧性尿失禁に対する恥骨後式と経閉鎖孔式中部尿道スリングの長期成績：再手術リスクと合併症 https://news.medxy.ai/vi/retropubic-vs-transobturator-midurethral-slings-for-stress-urinary-incontinence/Medxy AIvi2026-07-13T13:50:00-07:00Kết cục dài hạn của sling giữa niệu đạo đường sau xương mu so với đường xuyên lỗ bịt trong tiểu không tự chủ khi gắng sức: Nguy cơ phẫu thuật lại và biến chứng https://news.medxy.ai/long-term-outcomes-of-retropubic-vs-transobturator-midurethral-slings-for-stress-urinary-incontinence/Medxy AIen2026-07-13T13:49:11-07:00Long-Term Outcomes of Retropubic vs. Transobturator Midurethral Slings for Stress Urinary Incontinence: Reoperation Risks and Complications https://news.medxy.ai/vi/ischemic-placental-disease-for-neurological-and-psychiatric-disorders/Medxy AIvi2026-07-13T13:45:23-07:00Bệnh nhau thai thiếu máu cục bộ và nhập viện của mẹ vì rối loạn thần kinh, tâm thần: Tổng quan toàn diện https://news.medxy.ai/ischemic-placental-disease-and-maternal-hospitalization-for-neurological-and-psychiatric-disorders/Medxy AIen2026-07-13T13:44:12-07:00Ischemic Placental Disease and Maternal Hospitalization for Neurological and Psychiatric Disorders: A Comprehensive Review https://news.medxy.ai/zh/efficacy-of-native-tissue-hysteropexy-for-apical-pelvic-organ-prolapse/Medxy AIzh2026-07-13T13:38:27-07:00原位组织子宫固定术与子宫切除术治疗顶端盆腔器官脱垂：长期疗效与安全性比较 https://news.medxy.ai/ja/efficacy-and-safety-of-native-tissue-hysteropexy-for-apical-pelvic-organ-prolapse/Medxy AIja2026-07-13T13:38:09-07:00子宮温存術式はどこまで有利か？ 頂部骨盤臓器脱に対する native tissue hysteropexy と子宮摘出術の長期成績と安全性 https://news.medxy.ai/vi/efficacy-and-safety-of-native-tissue-hysteropexy-versus-hysterectomy-for-apical-pelvic-organ-prolapse/Medxy AIvi2026-07-13T13:37:47-07:00So sánh hiệu quả và độ an toàn dài hạn giữa hysteropexy bằng mô tự thân và cắt tử cung trong sa tạng chậu vùng đỉnh https://news.medxy.ai/comparing-long-term-efficacy-and-safety-of-native-tissue-hysteropexy-versus-hysterectomy-for-apical-pelvic-organ-prolapse/Medxy AIen2026-07-13T13:36:53-07:00Comparing Long-Term Efficacy and Safety of Native Tissue Hysteropexy Versus Hysterectomy for Apical Pelvic Organ Prolapse https://news.medxy.ai/zh/bile-acid-predict-portal-hypertension-and-esophageal-varices-post-kasai-in-biliary-atresia/Medxy AIzh2026-07-13T11:27:46-07:00血清胆汁酸：胆道闭锁 Kasai 术后门静脉高压与食管静脉曲张的早期预测指标 https://news.medxy.ai/ja/serum-bile-acid-as-early-predictors-of-portal-hypertension-and-esophageal-varices-post-kasai-in-biliary-atresia/Medxy AIja2026-07-13T11:27:27-07:00Kasai術後の胆道閉鎖症における門脈圧亢進症と食道静脈瘤を早期予測する血清胆汁酸 https://news.medxy.ai/vi/bile-acid-levels-as-early-predictors-of-portal-hypertension-and-esophageal-varices-post-kasai-in-biliary-atresia/Medxy AIvi2026-07-13T11:27:05-07:00Axit mật huyết thanh: dấu ấn sớm dự báo tăng áp lực tĩnh mạch cửa và giãn tĩnh mạch thực quản sau phẫu thuật Kasai ở teo đường mật https://news.medxy.ai/serum-bile-acid-levels-as-early-predictors-of-portal-hypertension-and-esophageal-varices-post-kasai-in-biliary-atresia/Medxy AIen2026-07-13T11:26:13-07:00Serum Bile Acid Levels as Early Predictors of Portal Hypertension and Esophageal Varices Post-Kasai in Biliary Atresia https://news.medxy.ai/vi/ibs-genetics-insights-into-cardiometabolic-and-triglyceride/Medxy AIvi2026-07-13T11:23:51-07:00Giải mã di truyền IBS: Các cơ chế liên quan tim mạch–chuyển hóa và triglyceride từ một phân tích gộp GWAS quy mô lớn https://news.medxy.ai/unraveling-ibs-genetics-insights-into-cardiometabolic-and-triglyceride-linked-mechanisms-from-a-large-gwas-meta-analysis/Medxy AIen2026-07-13T11:22:51-07:00Unraveling IBS Genetics: Insights into Cardiometabolic and Triglyceride-Linked Mechanisms from a Large GWAS Meta-Analysis https://news.medxy.ai/zh/dose-strategies-for-ustekinumab-in-crohns-disease/Medxy AIzh2026-07-13T11:19:36-07:00克罗恩病中乌司奴单抗剂量强化策略如何选择？REScUE试验带来新启示 https://news.medxy.ai/ja/dose-intensification-strategies-for-ustekinumab-in-crohns-disease/Medxy AIja2026-07-13T11:19:17-07:00クローン病におけるウステキヌマブ用量強化戦略を検証：REScUE試験からの知見 https://news.medxy.ai/vi/evaluating-dose-intensification-strategies-for-ustekinumab-in-crohns-disease/Medxy AIvi2026-07-13T11:18:57-07:00Đánh giá chiến lược tăng cường liều ustekinumab trong bệnh Crohn: Góc nhìn từ thử nghiệm REScUE https://news.medxy.ai/evaluating-dose-intensification-strategies-for-ustekinumab-in-crohns-disease-insights-from-the-rescue-trial/Medxy AIen2026-07-13T11:18:13-07:00Evaluating Dose Intensification Strategies for Ustekinumab in Crohn’s Disease: Insights from the REScUE Trial https://news.medxy.ai/zh/sex-differences-in-large-vessel-occlusion-screening-and-thrombectomy/Medxy AIzh2026-07-13T10:59:20-07:00女性卒中患者为何更容易漏筛大血管闭塞？——安大略省人群队列研究揭示血栓切除术结局的性别差异 https://news.medxy.ai/ja/sex-differences-in-large-vessel-occlusion-screening-thrombectomy-outcomes/Medxy AIja2026-07-13T10:59:01-07:00大血管閉塞スクリーニングと血栓回収療法転帰にみる性差：オンタリオ州の人口ベース・コホート研究からの示唆 https://news.medxy.ai/vi/sex-differences-in-large-vessel-occlusion-screening-and-thrombectomy-outcomes/Medxy AIvi2026-07-13T10:58:41-07:00Khác biệt giới trong sàng lọc tắc mạch lớn và kết quả thrombectomy: Góc nhìn từ nghiên cứu đoàn hệ dựa trên quần thể tại Ontario https://news.medxy.ai/sex-differences-in-large-vessel-occlusion-screening-and-thrombectomy-outcomes-insights-from-a-population-based-cohort-study-in-ontario/Medxy AIen2026-07-13T10:57:52-07:00Sex Differences in Large Vessel Occlusion Screening and Thrombectomy Outcomes: Insights from a Population-Based Cohort Study in Ontario https://news.medxy.ai/zh/premeal-insulin-enhances-postprandial-glucose-and-myocardial-microvascular-blood-flow-in-t1dm/Medxy AIzh2026-07-13T10:33:15-07:00餐前给胰岛素更关键：改善1型糖尿病餐后血糖控制与心肌微血管血流 https://news.medxy.ai/ja/premeal-insulin-enhances-postprandial-glucose-control-and-myocardial-microvascular-blood-flow-in-t1dm/Medxy AIja2026-07-13T10:32:57-07:00食前インスリンのタイミングが鍵：1型糖尿病における食後血糖と心筋微小循環を改善 https://news.medxy.ai/vi/premeal-insulin-enhances-postprandial-glucose-control-and-myocardial-microvascular-blood-flow-in-type-1-diabetes/Medxy AIvi2026-07-13T10:32:36-07:00Thời điểm dùng insulin rất quan trọng: Insulin trước bữa ăn cải thiện kiểm soát glucose sau ăn và tưới máu vi mạch cơ tim ở đái tháo đường type 1 https://news.medxy.ai/timing-matters-how-premeal-insulin-enhances-postprandial-glucose-control-and-myocardial-microvascular-blood-flow-in-type-1-diabetes/Medxy AIen2026-07-13T10:31:41-07:00Timing Matters: How Premeal Insulin Enhances Postprandial Glucose Control and Myocardial Microvascular Blood Flow in Type 1 Diabetes